Oral antidiabetic drugs in pregnancy: The other alternative

Diabetes Spectrum

Volumn 20, Issue 2, 2007, Pages 101-105

  Langer, Oded ^a  

^a University Hospital of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; INSULIN LISPRO; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE;

BLOOD GLUCOSE MONITORING; DECISION MAKING; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFECT; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MONOTHERAPY; NEWBORN INTENSIVE CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; REVIEW;

EID: 34250782307     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.20.2.101     Document Type: Review

References (56)

1. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP: The spread of the obesity epidemic in the United States. JAMA 282:1519-1522, 1999
2. Silverman BL, Rizzo TA, Cho NH, Metzger BE: Long-term effects of the intrauterine environment. Diabetes 21 (Suppl. 2):B142-B149, 1998
3. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 23 (Suppl. 2):S27-S31, 2000
5. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
6. Dornhorst A, Frost G: Nutritional management in diabetic pregnancy: a time for reason not dogma. In Diabetes and Pregnancy. Hod M, Jovanovic L, DiRenzo GC, deLevia A, Langer O, Eds. London, Taylor & Francis, 2003, p. 340-358
7. Langer O, Rodriguez DA, Xenakis EM, Mcfarland MB, Berkus MD, Arrendondo F: Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 170:1036-1047, 1994
8. Langer N: Culturally competent professionals in therapeutic alliances enhance patient compliance. J Health Care Poor Underserved 10:19-26, 1999
9. Langer N, Langer O: Gestational diabetes vs. pre-existing diabetes: comparison of pregnancy mood profiles. Diabetes Educ 26:667-672, 2000
10. Langer O, Langer N: Is cultural diversity a factor in self-monitoring blood glucose in gestational diabetes? J Assoc Minor Phys 6:73-77, 1995
11. Langer N, Langer O: Emotional adjustment to diagnosis and intensified treatment of gestational diabetes. Obstet Gynecol 84:329-334, 1994
12. Parretti E, Mecacci F, Papini M, Cioni R, Carignani L, Mignosa M, LaTorre P, Mello G: Third-trimester maternal glucose levels from diurnal profiles in non-diabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care 24:1319-1323, 2001
13. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O: Diurnal glycemic profile in obese and normal weight non-diabetic pregnant women. Am J Obstet Gynecol 191:1655-1660, 2004
14. American Diabetes Association: Gestational diabetes mellitus [Position Statement]. Diabetes Care 27 (Suppl 1):S88-S90, 2004
15. Metzger BE, Coustan DR, the Organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes. Diabetes Care 21 (Suppl. 2): B161-B167, 1998
16. Langer O: Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus. Diabetes Care 21 (Suppl. 2):B91-B98, 1998
17. Langer O, Berkus MD, Brustman L, Anyaegbunam A, Mazze R: Rationale for insulin management in gestational diabetes mellitus. Diabetes 40 (Suppl. 2):186-190, 1991
18. McFarland MB, Langer O, Conway DL, Berkus MD: Dietary therapy for gestational diabetes: how long is long enough? Obstet Gynecol 93:978-982, 1999
19. Langer O, Yogev Y, Xenakis E, Brustman L: Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol 192:1768-1776, 2005
20. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzalez O: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134-1138, 2000
21. Reece EA, Homko C, Miodovnik M, Langer O: A consensus report of the Diabetes in Pregnancy Study Group of North America Conference. J Maternal-Fetal Neonatal Med 12:362-364, 2002
22. Gabbe SG, Graves CR: Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 102:857-868, 2003
23. Greene MF: Oral hypoglycemic drugs for gestational diabetes [Editorial]. N Engl J Med 343:1178-1179, 2000
24. Cefalo RC: A comparison of glyburide and insulin in women with gestational diabetes mellitus. Obstet Gynecol Surv 56:126-127, 2001
25. Koren G: The use of glyburide in gestational diabetes: an ideal example of "bench to bed-side." Pediatr Res 49:734, 2001
26. Ryan EA: Glyburide was as safe and effective as insulin in gestational diabetes. EBM 6:79, 2001
27. Saade G: Gestational diabetes mellitus: a pill or a shot? Obstet Gynecol 105:456-457, 2005
28. Durnwald C, Landon MB: Glyburide: the new alternative for treating gestational diabetes? Am J Obstet Gynecol 193:1-2, 2005
29. Jovanovic L: The use of oral agents during pregnancy to treat gestational diabetes. Curr Diabetes Rep 1:69-70, 2001
30. Elliot BD, Langer O, Schenker S, Johnson RF: Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165:807-812, 1991
31. Elliot B, Schenker S, Langer O, Johnson R, Prihoda T: Comparative placental transport of oral hypoglycemic agents: a model of human placental drug transfer. Am J Obstet Gynecol 171:653-660, 1994
32. Elliot B, Langer O, Schussling F: A model of human placental drug transfer. Am J Obstet Gynecol 176:527-530, 1997
33. Koren G: Glyburide and fetal safety: transplacental pharmacokinetic considerations. Reprod Toxicol 15:227-229, 2001
34. Nanovskaya TN, Nekhayeva I, Hankins G, Ahmed M: Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol 72:632-639, 2006
35. Kraemer J, Klein J, Lubetsky A, Koren G: Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 195:270-274, 2006
36. Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Hankins GD, Ahmed MS: Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 195:1081-1085, 2006
37. Kovo M, Haroutiunian S, Feldman N: Determination of metformin transfer across the human placenta using dually perfused ex-vivo placental cotyledon model [Abstract]. Am J Obstet Gynecol 193:S85, 2005
38. Ruano R, Aubry MC, Barthe B, Mitanchez D, Dumez Y, Benachi A: Quantitative analysis of fetal pulmonary vasculature by 3-dimensional power Doppler ultrasonography in isolated congenital diaphragmatic hernia. Am J Obstet Gynecol 195:1720-1728, 2006
39. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O: Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 104:88-93, 2004
40. Langer O, Most O, Monga S: Glyburide: predictors of treatment failure in gestational diabetes [Abstract]. Am J Obstet Gynecol 195:S136, 2006
41. Hellmuth E, Damm P, Molsted-Pedersen L: Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 17:507-511, 2001
42. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR: Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 193:118-124, 2005
43. Fines V, Moore T, Castle S: A comparison of glyburide and insulin treatment in gestational diabetes mellitus on infant birth weight and adiposity [Abstract]. Am J Obstet Gynecol 189: S108, 2003
44. Conway DL, Gonzales O, Skiver D: Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med 15:51-55, 2004
45. Kremer CJ, Duff P: Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 190:1438-1439, 2004
46. Chmait R, Dinise T, Moore T: Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 24:617-622, 2004
47. Velazquez MD, Bolnick J, Cloakey D: The use of glyburide in the management of gestational diabetes. Obstet Gynecol 101 (Suppl.):88S, 2003
48. Pendsey SP, Sharma RR, Chalkhore SS: Repaglinide: a feasible alternative to insulin in management of gestational diabetes mellitus [Abstract]. Diabetes Res Clin Pract 56 (Suppl. 1):S46, 2002
49. Langer O, Yogev Y, Xenakis EM, Rosenn B: Insulin and glyburide therapy: dosage, severity level of gestational diabetes and pregnancy outcome. Am J Obstet Gynecol 192:134-139, 2005
50. Goetzel L, Wilkins I: Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol 22:403-406, 2002
51. Buxton ILO: Pharmacokinetics and pharmacodynamics. In Goodman and Gillman's The Pharmacologic Basis of Therapeutics. 11th ed. Brunton LL, Lazo JS, Parker KL, Eds. New York, McGraw Hill, 2002
52. Langer O: When diet fails: Insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes. J Maternal-Fetal Med 11:1-8, 2002
53. Langer O: Insulin and other treatment alternatives in gestational diabetes mellitus. Prenat Neonat Med 3:524-549, 1998
54. Langer O: Oral hypoglycemic agents and the pregnant diabetic: from bench to bedside. Sem Perinatol 26:196-205, 2002
55. Langer O: Management of gestational diabetes: pharmacologic treatment options and glycemic control. Endocrinol Metab Clin North Am 35:53-78, 2006
56. Langer O (Ed.): The Diabetes in Pregnancy Dilemma: Leading Changes With Simple Solutions. New York, University Press of America, 2006